Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Study acronym: SCALE-PD
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 4 months later Jun 2026 → Nov 2027
See other at-risk trials from Bodyport Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 2026 to Nov 2027
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Study sites: 3 to 4v6
  3. Site details revised at 1 of 3 sitesv5
  4. Study sites revised (3)v4
  5. Study sites: 1 to 3v3
  6. Start date changed from estimate of Jul 2025 to Sep 9, 2025v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Bodyport Inc.
2 trials monitored
See 1 trial at risk
Heart Disease
8,814 trials monitored
See 428 trials at risk
Heart Failure
2,000 trials monitored
See 115 trials at risk
Chronic Kidney Disease
1,423 trials monitored
See 70 trials at risk
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Trial Details
NCT Number NCT07059962
Lead Sponsor Bodyport Inc.
Conditions
(from sponsor)		 Kidney Disease, Peritoneal Dialysis (PD), End Stage Kidney Disease (ESRD)
Related terms Edema, Heart Failure, Kidney Diseases, Kidney Failure, Chronic
Enrollment 125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov